NT5C3A p.Phe31=
c.93C>T · VCV3766853
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP 3.5 | GERP 1.6, phastCons 1 |
| Overall | ||
| CADD | 15.2 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.00134% | 74,702 |
| European (non-Finnish) | 0.00017% | 589,317 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NT5C3A
- Protein
- p.Phe31=
- Coding
- c.93C>T
- MANE Select
- NM_001002010
- Type
- single nucleotide variant
- Location
- chr7:33062613 (GRCh38)
- Gene constraint
- LOEUF 1.137 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 92.29 · 3 PDB
Disease context
hemolytic anemia due to pyrimidine 5' nucleotidase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
Similar variants
- NT5C3A p.Phe31Leu Benign/Likely benign ★★ same residue
- POMP p.Leu31Phe Uncertain significance ★★ ⚠ same residue
- NT5C3A p.Asp132Val Pathogenic/Likely pathogenic ★★ same condition
- NT5C3A p.Asn259Ser Uncertain significance ★★ same condition
- NT5C3A p.Asp185Gly Uncertain significance ★★ same condition
- NT5C3A p.Glu301Asp Uncertain significance ★★ same condition
- NT5C3A p.Leu270Pro Uncertain significance ★★ same condition
- NT5C3A p.Lys109Gln Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nt5c3a-p-phe31 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown